Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score28
United States Fiscal year ends December CIK 0001061983
62.91
+1.45%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
62.91 on 9 Oct 2026
87 71 55 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $59.59 14 Oct 2025 $61.03 15 Oct 2025 $62.80 16 Oct 2025 $58.96 17 Oct 2025 $58.44 20 Oct 2025 $59.35 21 Oct 2025 $57.78 22 Oct 2025 $54.76 23 Oct 2025 $57.50 24 Oct 2025 $57.83 27 Oct 2025 $60.18 28 Oct 2025 $61.97 29 Oct 2025 $61.99 30 Oct 2025 $62.25 31 Oct 2025 $63.59 3 Nov 2025 $60.03 4 Nov 2025 $59.62 5 Nov 2025 $59.19 6 Nov 2025 $60.30 7 Nov 2025 $60.16 10 Nov 2025 $62.20 11 Nov 2025 $66.50 12 Nov 2025 $65.94 13 Nov 2025 $65.52 14 Nov 2025 $66.44 17 Nov 2025 $66.95 18 Nov 2025 $66.16 19 Nov 2025 $64.79 20 Nov 2025 $63.50 21 Nov 2025 $65.44 24 Nov 2025 $67.21 25 Nov 2025 $67.55 26 Nov 2025 $68.15 28 Nov 2025 $68.13 1 Dec 2025 $66.05 2 Dec 2025 $63.51 3 Dec 2025 $64.66 4 Dec 2025 $66.54 5 Dec 2025 $65.67 8 Dec 2025 $64.13 9 Dec 2025 $61.60 10 Dec 2025 $60.32 11 Dec 2025 $60.77 12 Dec 2025 $63.35 15 Dec 2025 $62.16 16 Dec 2025 $62.02 17 Dec 2025 $59.82 18 Dec 2025 $62.20 19 Dec 2025 $62.72 22 Dec 2025 $65.60 23 Dec 2025 $63.29 24 Dec 2025 $64.18 26 Dec 2025 $63.11 29 Dec 2025 $61.75 30 Dec 2025 $61.37 31 Dec 2025 $63.54 2 Jan 2026 $61.73 5 Jan 2026 $61.26 6 Jan 2026 $64.60 7 Jan 2026 $65.42 8 Jan 2026 $63.32 9 Jan 2026 $62.51 12 Jan 2026 $64.64 13 Jan 2026 $63.33 14 Jan 2026 $64.60 15 Jan 2026 $63.44 16 Jan 2026 $62.58 20 Jan 2026 $63.78 21 Jan 2026 $63.04 22 Jan 2026 $64.93 23 Jan 2026 $63.41 26 Jan 2026 $63.19 27 Jan 2026 $64.01 28 Jan 2026 $65.14 29 Jan 2026 $65.60 30 Jan 2026 $63.19 2 Feb 2026 $65.16 3 Feb 2026 $64.73 4 Feb 2026 $63.52 5 Feb 2026 $60.24 6 Feb 2026 $62.34 9 Feb 2026 $63.36 10 Feb 2026 $64.85 11 Feb 2026 $66.80 12 Feb 2026 $65.04 13 Feb 2026 $66.26 17 Feb 2026 $66.62 18 Feb 2026 $66.98 19 Feb 2026 $67.83 20 Feb 2026 $67.94 23 Feb 2026 $68.26 24 Feb 2026 $70.10 25 Feb 2026 $62.89 26 Feb 2026 $62.63 27 Feb 2026 $62.22 2 Mar 2026 $61.43 3 Mar 2026 $60.72 4 Mar 2026 $62.27 5 Mar 2026 $62.19 6 Mar 2026 $60.41 9 Mar 2026 $62.42 10 Mar 2026 $64.20 11 Mar 2026 $63.63 12 Mar 2026 $60.00 13 Mar 2026 $60.06 16 Mar 2026 $60.83 17 Mar 2026 $62.13 18 Mar 2026 $62.19 19 Mar 2026 $62.95 20 Mar 2026 $61.70 23 Mar 2026 $60.95 24 Mar 2026 $60.02 25 Mar 2026 $62.39 26 Mar 2026 $63.48 27 Mar 2026 $62.50 30 Mar 2026 $62.97 31 Mar 2026 $65.91 1 Apr 2026 $66.61 2 Apr 2026 $66.73 6 Apr 2026 $64.94 7 Apr 2026 $65.48 8 Apr 2026 $65.77 9 Apr 2026 $64.59 10 Apr 2026 $65.01 13 Apr 2026 $66.72 14 Apr 2026 $66.35 15 Apr 2026 $65.37 16 Apr 2026 $65.42 17 Apr 2026 $66.71 20 Apr 2026 $66.14 21 Apr 2026 $65.80 22 Apr 2026 $66.25 23 Apr 2026 $65.48 24 Apr 2026 $65.32 27 Apr 2026 $61.60 28 Apr 2026 $60.69 29 Apr 2026 $59.58 30 Apr 2026 $63.97 1 May 2026 $63.35 4 May 2026 $66.05 5 May 2026 $77.09 6 May 2026 $74.84 7 May 2026 $74.29 8 May 2026 $76.91 11 May 2026 $74.56 12 May 2026 $74.81 13 May 2026 $77.22 14 May 2026 $78.64 15 May 2026 $75.85 18 May 2026 $75.18 19 May 2026 $76.45 20 May 2026 $78.77 21 May 2026 $78.06 22 May 2026 $76.94 26 May 2026 $76.29 27 May 2026 $77.15 28 May 2026 $76.81 29 May 2026 $76.76 1 Jun 2026 $73.68 2 Jun 2026 $70.91 3 Jun 2026 $70.71 4 Jun 2026 $72.29 5 Jun 2026 $71.48 8 Jun 2026 $67.90 9 Jun 2026 $68.45 10 Jun 2026 $67.07 11 Jun 2026 $69.27 12 Jun 2026 $70.15 15 Jun 2026 $71.38 16 Jun 2026 $75.21 17 Jun 2026 $78.11 18 Jun 2026 $78.78 22 Jun 2026 $79.17 23 Jun 2026 $80.01 24 Jun 2026 $81.20 25 Jun 2026 $80.80 26 Jun 2026 $82.19 29 Jun 2026 $87.26 30 Jun 2026 $85.19 1 Jul 2026 $85.26 2 Jul 2026 $86.49 6 Jul 2026 $85.57 7 Jul 2026 $85.56 8 Jul 2026 $84.88 9 Jul 2026 $86.07 10 Jul 2026 $84.87 13 Jul 2026 $82.24 14 Jul 2026 $81.93 15 Jul 2026 $82.62 16 Jul 2026 $80.36 17 Jul 2026 $80.18 20 Jul 2026 $79.11 21 Jul 2026 $81.11 22 Jul 2026 $82.19 23 Jul 2026 $81.92 24 Jul 2026 $80.74 27 Jul 2026 $80.62 28 Jul 2026 $79.45 29 Jul 2026 $78.39 30 Jul 2026 $80.42 31 Jul 2026 $77.13 3 Aug 2026 $76.45 4 Aug 2026 $78.61 5 Aug 2026 $78.85 6 Aug 2026 $81.37 7 Aug 2026 $76.76 10 Aug 2026 $77.49 11 Aug 2026 $76.45 12 Aug 2026 $75.64 13 Aug 2026 $73.45 14 Aug 2026 $74.13 17 Aug 2026 $75.87 18 Aug 2026 $76.10 19 Aug 2026 $77.74 20 Aug 2026 $77.18 21 Aug 2026 $76.84 24 Aug 2026 $77.09 25 Aug 2026 $77.46 26 Aug 2026 $79.20 27 Aug 2026 $77.90 28 Aug 2026 $72.09 31 Aug 2026 $70.91 1 Sep 2026 $71.40 2 Sep 2026 $71.93 3 Sep 2026 $73.95 4 Sep 2026 $72.72 8 Sep 2026 $75.35 9 Sep 2026 $74.11 10 Sep 2026 $73.62 11 Sep 2026 $73.77 14 Sep 2026 $72.45 15 Sep 2026 $69.31 16 Sep 2026 $69.39 17 Sep 2026 $69.92 18 Sep 2026 $68.78 21 Sep 2026 $67.56 22 Sep 2026 $67.59 23 Sep 2026 $65.81 24 Sep 2026 $65.66 25 Sep 2026 $64.66 28 Sep 2026 $66.16 29 Sep 2026 $65.64 30 Sep 2026 $65.91 1 Oct 2026 $65.62 2 Oct 2026 $65.60 5 Oct 2026 $62.70 6 Oct 2026 $61.35 7 Oct 2026 $61.12 8 Oct 2026 $62.01 9 Oct 2026 $62.91 Blum Robert I President & CEO Sold on a plan $300.15K 16 Oct 2025 · at $60.03 · 1.4% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $122.55K 21 Oct 2025 · at $58.22 · 1.5% of stake WIERENGA WENDELL Director Sold on a plan $256.73K 27 Oct 2025 · at $58.68 · 11.9% of stake Blum Robert I President & CEO Sold on a plan $314.30K 30 Oct 2025 · at $62.86 · 1.4% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $136.67K 4 Nov 2025 · at $59.55 · 1.6% of stake Kaye Edward M. MD Director Sold on a plan $336.79K 11 Nov 2025 · at $65.08 · 34.2% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $146.19K 18 Nov 2025 · at $66.45 · 1.5% of stake PARSHALL B LYNNE Director Sold on a plan $323.65K 19 Nov 2025 · at $64.73 · 17.9% of stake Harrington Robert Arthur Director Sold on a plan $143.62K 1 Dec 2025 · at $66.80 · 10.4% of stake Kaye Edward M. MD Director Sold on a plan $1.87M 1 Dec 2025 · at $66.72 · 73.8% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $140.56K 2 Dec 2025 · at $63.89 · 1.5% of stake HENDERSON JOHN T Director Sold on a plan $559.13K 2 Dec 2025 · at $63.90 · 10.5% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $3.46M 5 Dec 2025 · at $65.95 · 50.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $68.73K 8 Dec 2025 · at $65.96 · 2.0% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $134.73K 16 Dec 2025 · at $61.24 · 1.6% of stake WIERENGA WENDELL Director Sold on a plan $1.32M 22 Dec 2025 · at $66.14 · 38.1% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $112.95K 29 Dec 2025 · at $62.44 · 3.4% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $112.58K 2 Jan 2026 · at $62.62 · 3.4% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $904.20K 5 Jan 2026 · at $60.28 · 22.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $55.02K 2 Feb 2026 · at $62.10 · 1.7% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $928.95K 5 Feb 2026 · at $61.93 · 22.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $54.60K 2 Mar 2026 · at $61.62 · 1.7% of stake PARSHALL B LYNNE Director Sold on a plan $306.05K 2 Mar 2026 · at $61.21 · 21.8% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $1.61M 5 Mar 2026 · at $61.87 · 34.0% of stake Callos Andrew EVP, Chief Commercial Officer Sold at will $156.78K 9 Mar 2026 · at $60.72 · 5.1% of stake Malik Fady Ibraham EVP Research & Development Sold at will $176.51K 9 Mar 2026 · at $60.72 · 2.1% of stake Blum Robert I President & CEO Sold at will $481.57K 9 Mar 2026 · at $60.72 · 2.0% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $104.30K 16 Mar 2026 · at $61.03 · 3.6% of stake Lee Sung EVP, Chief Financial Officer Sold at will $306.71K 17 Mar 2026 · at $62.15 · 5.4% of stake Callos Andrew EVP, Chief Commercial Officer Sold at will $530.89K 17 Mar 2026 · at $62.15 · 10.7% of stake Malik Fady Ibraham EVP Research & Development Sold at will $747.85K 17 Mar 2026 · at $62.15 · 7.3% of stake Blum Robert I President & CEO Sold at will $2.27M 17 Mar 2026 · at $62.15 · 7.8% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $119.80K 18 Mar 2026 · at $62.07 · 2.4% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $236.54K 31 Mar 2026 · at $65.00 · 5.2% of stake Blum Robert I President & CEO Sold on a plan $499.73K 1 Apr 2026 · at $66.63 · 1.7% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $292.99K 7 Apr 2026 · at $65.11 · 2.8% of stake Blum Robert I President & CEO Sold on a plan $490.35K 15 Apr 2026 · at $65.38 · 1.8% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $491.78K 15 Apr 2026 · at $66.02 · 11.3% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $229.92K 21 Apr 2026 · at $65.69 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $447.15K 29 Apr 2026 · at $59.62 · 1.8% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $948.90K 30 Apr 2026 · at $63.26 · 20.4% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $1.03M 1 May 2026 · at $65.00 · 21.3% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $270.80K 5 May 2026 · at $77.37 · 2.2% of stake WIERENGA WENDELL Director Sold on a plan $302.40K 5 May 2026 · at $75.00 · 11.0% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $875.47K 5 May 2026 · at $77.25 · 16.2% of stake HENDERSON JOHN T Director Sold on a plan $1.52M 5 May 2026 · at $75.97 · 21.0% of stake Lee Sung EVP, Chief Financial Officer Sold on a plan $1.84M 5 May 2026 · at $76.87 · 27.4% of stake Blum Robert I President & CEO Sold on a plan $584.40K 14 May 2026 · at $77.92 · 1.8% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $264.92K 19 May 2026 · at $75.69 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $579.08K 27 May 2026 · at $77.21 · 1.9% of stake Kaye Edward M. MD Director Sold on a plan $223.17K 1 Jun 2026 · at $76.09 · 22.2% of stake PARSHALL B LYNNE Director Sold on a plan $370.40K 1 Jun 2026 · at $74.08 · 24.1% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $1.11M 1 Jun 2026 · at $74.08 · 20.4% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $237.93K 9 Jun 2026 · at $67.98 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $528.45K 15 Jun 2026 · at $70.46 · 1.9% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $278.29K 23 Jun 2026 · at $79.51 · 2.2% of stake Lee Sung EVP, Chief Financial Officer Sold on a plan $3.19M 24 Jun 2026 · at $82.30 · 38.0% of stake Lee Sung EVP, Chief Financial Officer Sold on a plan $266.39K 29 Jun 2026 · at $85.00 · 4.7% of stake Lee Sung EVP, Chief Financial Officer Sold on a plan $97.62K 1 Jul 2026 · at $87.79 · 1.7% of stake Blum Robert I President & CEO Sold on a plan $636.90K 1 Jul 2026 · at $84.92 · 1.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $1.29M 1 Jul 2026 · at $85.80 · 20.4% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $303.17K 7 Jul 2026 · at $86.62 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $615.15K 13 Jul 2026 · at $82.02 · 1.9% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $282.07K 21 Jul 2026 · at $80.59 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $606.53K 27 Jul 2026 · at $80.87 · 1.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $1.12M 30 Jul 2026 · at $79.88 · 19.3% of stake Blum Robert I President & CEO Sold on a plan $575.70K 10 Aug 2026 · at $76.76 · 1.9% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $265.37K 18 Aug 2026 · at $75.82 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $526.80K 31 Aug 2026 · at $70.24 · 1.9% of stake Callos Andrew EVP, Chief Commercial Officer Sold on a plan $702.40K 31 Aug 2026 · at $70.24 · 14.6% of stake PARSHALL B LYNNE Director Sold on a plan $357.40K 1 Sep 2026 · at $71.48 · 31.7% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $264.11K 8 Sep 2026 · at $75.46 · 2.2% of stake Landry Robert E Director Sold on a plan $74.66K 11 Sep 2026 · at $74.66 · 9.8% of stake Blum Robert I President & CEO Sold on a plan $550.80K 14 Sep 2026 · at $73.44 · 1.9% of stake Landry Robert E Director Sold on a plan $72.13K 15 Sep 2026 · at $72.13 · 10.9% of stake Blum Robert I President & CEO Sold on a plan $6.79M 15 Sep 2026 · at $69.33 · 100% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $239.02K 22 Sep 2026 · at $68.29 · 2.2% of stake Blum Robert I President & CEO Sold on a plan $490.95K 28 Sep 2026 · at $65.46 · 2.6% of stake Malik Fady Ibraham EVP Research & Development Sold on a plan $214.83K 6 Oct 2026 · at $61.38 · 2.2% of stake
0 buys7 sales at will72 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$88.04M
Net income
$784.96M
Free cash flow
$534.82M
Operating margin
-695.4%
Net margin
-891.6%
Revenue growth, 1 yr
376.6%
Revenue growth, 5 yr
9.5% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
56M -127M FY20 Fiscal year 2020 Revenue $55.83M Net income $127.29M Margin -228.0% 70M -215M FY21 Fiscal year 2021 Revenue $70.43M Net income $215.31M Margin -305.7% · growth +26.2% 95M -389M FY22 Fiscal year 2022 Revenue $94.59M Net income $388.96M Margin -411.2% · growth +34.3% 8M -526M FY23 Fiscal year 2023 Revenue $7.53M Net income $526.24M Margin -6,988.6% · growth -92.0% 18M -590M FY24 Fiscal year 2024 Revenue $18.47M Net income $589.53M Margin -3,191.1% · growth +145.3% 88M -785M FY25 Fiscal year 2025 Revenue $88.04M Net income $784.96M Margin -891.6% · growth +376.6%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
6 Oct 2026 Malik Fady Ibraham
EVP Research & Development
Sold on a plan $214.83K 2.2%
28 Sep 2026 Blum Robert I
President & CEO
Sold on a plan $490.95K 2.6%
22 Sep 2026 Malik Fady Ibraham
EVP Research & Development
Sold on a plan $239.02K 2.2%
15 Sep 2026 Blum Robert I
President & CEO
Sold on a plan $6.79M 100%
15 Sep 2026 Landry Robert E
Director
Sold on a plan $72.13K 10.9%
14 Sep 2026 Blum Robert I
President & CEO
Sold on a plan $550.80K 1.9%